Back to search results

Longitudinal Cohort Study of Immune-Related Adverse Events in Solid Tumor Patients Treated With Immune Checkpoint Inhibitors

Abroad (travel likely)Recruiting

Conditions

Solid Tumor · Immune-Related Adverse Events · Immunotherapy Toxicity

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, China

    Contact: Study coordinator (Yifei Ma, MD) · myf61872169@163.com · 8618883852716
    Contact: Principal Investigator (Yifei Ma, MD)

  • Sun Yat-sen University Cancer Center, Guangzhou, China

    Contact: Study coordinator (Ao Zhang, MD) · zhangao@sysucc.org.cn · 8618588811852
    Contact: Principal Investigator (Ao Zhang, MD)

  • Hainan Hospital of Chinese PLA General Hospital, Sanya, China

    Contact: Study coordinator (Jiacai Lin, MD) · sovereignljc@126.com · 8615692537693
    Contact: Principal Investigator (Jiacai Lin, MD)

  • Affiliated Cancer Hospital of Shantou University Medical College, Shantou, China

    Contact: Study coordinator (Xinjia Wang, MD) · liuhaizhou@fjmu.edu.cn · 8613881841142
    Contact: Principal Investigator (Xinjia Wang, MD)

  • the First Affiliated Hospital of Shantou University Medical College, Shantou, China

    Contact: Study coordinator (Jun Lu, MD) · jlu1@stu.edu.cn · 8613531263375
    Contact: Principal Investigator (Jun Lu, MD)

  • The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China

    Contact: Study coordinator (Pengfei Zhu, MD) · tesolik_trevolso@tom.com · 8613526664537
    Contact: Principal Investigator (Pengfei Zhu, MD)
View source on ClinicalTrials.gov(opens in a new tab)